Despite its potential, BNCT faces several challenges. One major limitation is the need for effective boron delivery agents that can selectively accumulate in cancer cells. Additionally, the availability of suitable neutron sources is a logistical and technical challenge. Most clinical BNCT facilities require specialized reactors or accelerators, which are not widely available. Furthermore, the treatment planning and dosimetry for BNCT are complex and require specialized expertise.
